United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2014_register executive 2014-11-19 article Notices D09002ee1c7f83a89 D09002ee1c7f83b07 United States Department of Health and Human Services originator org United States Government Agency or Subagency United States National Institutes of Health originator org United States Government Agency or Subagency This is notice, in accordance with 35 U.S.C. 209 and 37 CFR Part 404, that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of an exclusive patent license to Amprion, Inc. located in Houston Texas, USA, to practice the inventions embodied in the following Patents and Patent Applications, each entitled "Detection of Infectious Prion Protein by Seeded Conversion of Recombinant Prion Protein": 1. US provisional Application 60/961,364 filed July 20, 2007 [HHS Ref. No. E-109-2007/0-US-01] 2. PCT/US2008/070656, filed July 21, 2008; [HHS Ref. No E-109-2007/ 1-PCT-01] 3. EPC application No 08796382.3 filed July 21, 2008 [HHS Ref. No E-109-2007/1-EP-03] 4. US Application No. 12/177,012, filed July 21, 2008 and issued as US patent 8,216,788 on July 10, 2012 [HHS Ref. No E-109-2007/1-US-02]; 5. US Application No. 13/489,321, filed June 5, 2012 [E-109-2007/1- US-04]; 6. US Application No. 14/263,703, filed April 28, 2014 [E-109-2007/ 1-US-011] The patent rights in these inventions have been assigned to the United States of America. The prospective exclusive licensed territory may be worldwide and the field of use may be limited to in vitro diagnostics of prion- associated diseases requiring FDA premarket approval, or the equivalent thereof outside of the United States, and USDA licensed veterinary diagnostics, or the equivalents thereof outside of the United States. 79 FR 68892 https://www.govinfo.gov/app/details/FR-2014-11-19/2014-27342 2014-27342 fr19no14-59 4140-01-P https://www.govinfo.gov/app/details/FR-2014-11-19/2014-27342 https://www.govinfo.gov/content/pkg/FR-2014-11-19/html/2014-27342.htm https://www.govinfo.gov/content/pkg/FR-2014-11-19/pdf/2014-27342.pdf 2 p. 68892 68893 79 FR 68892 Prospective Grant of Exclusive License: Detection of Infectious Prion Protein by Seeded Conversion of Recombinant Prion Protein; Federal Register Vol. 79, Issue NOTICE 2014-27342 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health 2014-12-19 4140-01-P 2014-27342 Notice.

This is notice, in accordance with 35 U.S.C. 209 and 37 CFR Part 404, that the National Institutes of Health (NIH), Department of Health and Human Services, is contemplating the grant of an exclusive patent license to Amprion, Inc. located in Houston Texas, USA, to practice the inventions embodied in the following Patents and Patent Applications, each entitled "Detection of Infectious Prion Protein by Seeded Conversion of Recombinant Prion Protein": 1. US provisional Application 60/961,364 filed July 20, 2007 [HHS Ref. No. E-109-2007/0-US-01] 2. PCT/US2008/070656, filed July 21, 2008; [HHS Ref. No E-109-2007/ 1-PCT-01] 3. EPC application No 08796382.3 filed July 21, 2008 [HHS Ref. No E-109-2007/1-EP-03] 4. US Application No. 12/177,012, filed July 21, 2008 and issued as US patent 8,216,788 on July 10, 2012 [HHS Ref. No E-109-2007/1-US-02]; 5. US Application No. 13/489,321, filed June 5, 2012 [E-109-2007/1- US-04]; 6. US Application No. 14/263,703, filed April 28, 2014 [E-109-2007/ 1-US-011] The patent rights in these inventions have been assigned to the United States of America. The prospective exclusive licensed territory may be worldwide and the field of use may be limited to in vitro diagnostics of prion- associated diseases requiring FDA premarket approval, or the equivalent thereof outside of the United States, and USDA licensed veterinary diagnostics, or the equivalents thereof outside of the United States.

Only written comments and/or application for a license that are received by the NIH Office of Technology Transfer on or before 11:59 p.m. Eastern Time on December 19, 2014 will be considered. Exclusive Licenses: Detection of Infectious Prion Protein by Seeded Conversion of Recombinant Prion Protein , fennea@mail.nih.gov Vol. 79, no. 223 Office of the Federal Register, National Archives and Records Administration 2014-11-19 continuing daily deposited born digital 282 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2014-11-19 P0b002ee18a252612 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr19no14 https://www.govinfo.gov/app/details/FR-2014-11-19 https://www.govinfo.gov/content/pkg/FR-2014-11-19/pdf/FR-2014-11-19.pdf https://www.govinfo.gov/content/pkg/FR-2014-11-19/xml/FR-2014-11-19.xml fdlp 68759 69031 DGPO 2014-11-19 2024-06-02 FR-2014-11-19 machine generated eng FR FR-2014-11-19 79 223